Ghemaxan

Ghemaxan is an anticoagulant medication containing Enoxaparin Sodium, used to prevent and treat blood clots. It is suitable for haemodialysis, intraarterial, and intravenous use.

Ghemaxan is primarily used to prevent and treat blood clots in various medical conditions. It is often administered during haemodialysis to maintain the patency of the dialysis circuit. Additionally, it can be used intraarterially or intravenously to manage clotting risks during certain procedures.

Ghemaxan works by inhibiting the formation of blood clots, which helps to maintain blood flow in medical devices like dialysis machines. Common effects may include bruising or bleeding at the injection site, as well as potential systemic bleeding if not used as directed.

Ghemaxan should be handled with care to avoid accidental injury. It is important to follow medical guidance for administration and to monitor for signs of bleeding. Patients with a history of bleeding disorders or allergies to heparin should consult a healthcare provider before use.

Ghemaxan may interact with other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs), increasing the risk of bleeding. Alcohol consumption should be moderated, as it can also affect blood clotting mechanisms.